US approves first nasal spray for anaphylaxis

被引：0

|

作者：

Mahase, Elisabeth

机构：

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2024年 / 386卷

关键词：

D O I：

10.1136/bmj.q1789

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页数：1

相关论文

共 50 条

[1] FDA Approves First Epinephrine Nasal Spray
Aschenbrenner, Diane S.
AMERICAN JOURNAL OF NURSING, 2024, 124 (12) : 17 - 17
[2] US FDA approves first generic naloxone spray
Reactions Weekly, 2019, 1750 (1) : 7 - 7
[3] FDA approves first naloxone nasal spray for opioid overdose
Reactions Weekly, 2015, 1580 (1) : 1 - 1
[4] FDA approves migraine nasal spray
不详
NURSE PRACTITIONER, 2023, 48 (05): : 48 - 48
[5] FDA approves first OTC naloxone nasal spray for reversal of opioid overdose
Reactions Weekly, 2023, 1952 (1) : 3 - 3
[6] An Epinephrine Nasal Spray (neffy) for Anaphylaxis
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2024, 66 (1713):
[7] FDA Fast-Tracks First Nasal Spray for Allergic Reactions, Anaphylaxis
Anderer, Samantha
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 332 (13):
[8] FDA Approves Easy-to-use Naloxone Nasal Spray
不详
JOURNAL OF PAIN & PALLIATIVE CARE PHARMACOTHERAPY, 2016, 30 (01) : 77 - +
[9] FDA approves RiVive naloxone nasal spray for opioid overdose
Reactions Weekly, 2023, 1969 (1) : 2 - 2
[10] FDA approves naloxone 8mg nasal spray for opioid overdose
Reactions Weekly, 2021, 1855 (1) : 3 - 3

← 1 2 3 4 5 →